Onset of Plaque Psoriasis Treatment Responses With Anti-IL-17/IL-23 Biologic Therapies. | J Drugs Dermatol;21(8): 854-860, 2022 Aug 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Onset of Plaque Psoriasis Treatment Responses With Anti-IL-17/IL-23 Biologic Therapies.

Fried, Richard; Lebwohl, Mark; Bettencourt, Miriam; Koo, John; Jacobson, Abby.

J Drugs Dermatol ; 21(8): 854-860, 2022 Aug 01.

Article in En | MEDLINE | ID: mdl-35946972

Subject(s)

Psoriasis; Quality of Life; Biological Therapy; Humans; Interleukins; Pain; Pruritus/drug therapy; Pruritus/etiology; Psoriasis/diagnosis; Psoriasis/drug therapy; Severity of Illness Index; Treatment Outcome

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Quality of Life Type of study: Diagnostic_studies / Etiology_studies Limits: Humans Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2022 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Quality of Life Type of study: Diagnostic_studies / Etiology_studies Limits: Humans Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2022 Type: Article